Vera Therapeutics, Inc DEFA14A, filed Apr 14, 2022
Vera Therapeutics, Inc. (VERA)
DEFA14A
2022-04-14
View Original
Added on
October 24, 2026
SCHEDULE 14A INFORMATION
Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934
(Amendment No.)
|
Filed by the Registrant
|
☒ |
|
Filed by a party other than the Registrant
|
☐ |
Check the appropriate box:
| ☐ |
Preliminary Proxy Statement
|
| ☐ |
Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
|
| ☐ |
Definitive Proxy Statement
|
| ☒ |
Definitive Additional Materials
|
| ☐ |
Soliciting Material Pursuant to § 240.14a-12
|
|
Vera Therapeutics, Inc.
|
|
(Name of Registrant as Specified In Its Charter)
|
|
N/A
|
|
(Name of Person(s) Filing Proxy Statement if other than the Registrant)
|
Payment of Filing Fee (Check the appropriate box):
| ☒ |
No fee required
|
| ☐ |
Fee paid previously with preliminary materials
|
| ☐ |
Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11
|
